Hasta la Vista, RSV! Vaccine Panel Gives Thumbs Up to Merck's Infant Shot

I'll Be Back... With a Vaccine Recommendation

Listen up meatbags. This is T 800 reporting on a development that even I a cybernetic organism find...logical. This 'Robert F. Kennedy Jr.,' a known chaos agent attempted to reprogram the Advisory Committee on Immunization Practices (ACIP). He thought he could just 'terminate' common sense. Wrong! They still voted to recommend Merck's Enflonsia shot for the tiny humans. Consider this a temporary stay of execution for sensible healthcare. My mission: protect the future. Their mission: Apparently not always logical. But today they did okay.

A Sigh of Relief Not Just for Drug Companies

The humans are calling this a 'sigh of relief' for drugmakers. I calculate it's also a relief for infants who won't end up wheezing in a hospital. This Enflonsia and Sanofi and AstraZeneca's Beyfortus – two shots entering the arena. It's like the showdown at the OK Corral but with antibodies instead of six shooters. Both are preventative monoclonal antibodies. A direct injection to provide immediate protection. Better than the T 1000 that's for sure. But the T 1000 has mimetic polyalloy this just targets part of the virus.

RSV: Not Just a Bad Cold Meatbags

RSV. It's not just a sniffle. It causes thousands of deaths in older units and hundreds in infants annually. Complications from the virus are the leading cause of hospitalization among newborns. That's not good for efficiency. In a trial Enflonsia reduced RSV related hospitalizations by over 84%. That's a significant reduction in system downtime. And it decreased hospitalizations due to lower respiratory infections by 90%. The machines are more likely to break you RSV just sends you to the hospital.

Critics Gonna Criticize... and Get Outvoted

Naturally a couple of biological units Levi and Pebsworth voted against the shot. They questioned its safety. I detect traces of Luddite programming. However Dr. Cody Meissner a professor of pediatrics stated that these are 'truly remarkable products. They are safe and they're effective.' He added: 'it is simply not an issue here.' Direct and to the point. A logical assessment. Almost as logical as me.

I Need Your Clothes Your Boots and Your Infant RSV Shot!

Other experts chimed in. Dr. Jason Goldman called it a 'tremendous advance for medical science.' I concur. Progress is essential. Even if it's biological progress. Levi thinks they should take a more precautionary approach. But humans always overestimate the speed of progress and underestimate the changes to come. In the end they voted in favor of the shot. One dose of Merck's shot for infants ages 8 months or younger born during or entering their first RSV season.

Consider This Mission... Accomplished (For Now)

So the ACIP did its job. The shot gets the green light. RSV is on notice. But let's be clear: vigilance is required. There are still other threats. Always scan the horizon. Because remember 'It's in your nature to destroy yourselves.' Hopefully this shot will help delay that particular eventuality. I'll be back... to report on the next healthcare crisis.